Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for sedation in endovascular stroke treatment
NCT01845441Phase 2Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Apr 2012
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in ischemic stroke, cerebral vasospasm, sponsored by University Hospitals Cleveland Medical Center. Started Apr 2012; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
ischemic strokecerebral vasospasm
Beyond the preview
Go deeper on NCT01845441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845441.